M

Researcher Profile

Mark-David Levin

🏛 30Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands

3

Publications

108

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article Blood Nov 03, 2025

Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia: Results from the randomized CLL17 trial

Othman Al-Sawaf · Janina Stumpf · Can Zhang · Florian Simon +49 more

10.1182/blood-2025-1 3 citations

Journal Article Blood Nov 03, 2025

Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age

Peter Voorhees · Meletios Dimopoulos · Yael Cohen · Fredrik Schjesvold +35 more

10.1182/blood-2025-372 2 citations

Open Access Journal Article The Lancet Oncology Aug 01, 2024

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Philippe Moreau · Cyrille Hulin · Aurore Perrot · Bertrand Arnulf +46 more

10.1016/s1470-2045(24)00282-1 103 citations

Publication Timeline

2025

2

2024

1

Frequent Co-Authors

Philippe Moreau

Soraya Wuillème

Irwindeep Sandhu

Sandra Robrecht

Kirsten Fischer